श्रीरंग बारणेंना खासदार बनवण्यासाठी सुधाकर भाऊ घारेंनी लावली ताकत : कर्जत- खालापूर मतदारसंघात आढावा बैठकांचे सत्र सुरु-Dr L H Hiranandani Hospital marks 50 Bone Marrow Transplants-Bank of Baroda ropes in Kunaal Roy Kapur for PehchaanCon 3.0 campaign to spread awareness on new-age financial frauds-आजच्या युगातील आर्थिक फसवणुकीबद्दल जागरुकता निर्माण करण्यासाठी बँक ऑफ बडोदाने पेहचानकॉन 3.0 कॅम्पेनसाठी केली कुणाल रॉय कपूरशी हातमिळवणी.-GJEPC: The Authorized Economic Operator (AEO) Status Now Extended To The Gem & Jewellery Sector-GJEPC: Plain Gold Jewellery Exports Grew by 61.72% to US$ 6792.24 million in FY 2023-24-Dabur Glucose launches ‘Energize India’ Campaign to Promote Young Athletes-The Yoga Institute Santa Cruz, Mumbai Announces Free Access to "Samattvam" Yoga OPD in Honor of Dr. Jayadeva Yogendra's Birth Anniversary on 27th April 2024-Bullet Echo India scales the Google Play Store charts; KRAFTON and ZeptoLab officially announce the launch of the game in India-ड्रोन डेस्टिनेशनने 'डेंटसू क्रिएटिव्ह पीआर'ची पीआर एजन्सी म्हणून नियुक्ती केली

NARAYANA Hrudayalaya Limited Q3FY16 Consolidated operating income at Rs 3,981 mn (y-o-y of 16.7%) with EBITDA of Rs 437 mn (y-o-y of 113.6%)

9 Months FY16 Consolidated operating income at Rs 11,815 mn (y-o-y of 18.1%) with EBITDA of Rs 1,361 mn (y-o-y of 52.9%)

 
Mumbai, India, February 11,2016 – Narayana Hrudayalaya Limited (BSE:539551, NSE: NHL), a leading healthcare service provider in India, today announced its financial results for the third quarter (Q3FY16) and nine months’ period (9 Months FY16) ended December 31st,2015.
 
Key Highlights for the Quarter (Q3FY16) 
§  Consolidated total operating income was Rs 3,981 mn for Q3FY16 as compared to Rs 3,413 mn in the corresponding period of the previous year reflecting an increase of 16.7%
§  Consolidated EBITDA stood at Rs 437 mn as compared to Rs 205 mn during the corresponding period of previous year reflecting an increase of 113.6%
§  Consolidated EBITDA Margin was at 11.0 % for Q3FY16 as against 6.0 % in Q3FY15
§  PAT after minority interest and share in associate stood at Rs 37 mn for Q3FY16 as compared to negative Rs (141) mn in the corresponding period of the previous year
 
Key Highlights for YTD Dec 2015 (9 Months FY 16)
§  Consolidated total operating income was Rs 11,815 mn for 9 Months FY16 as compared to Rs 10,005 mn in the corresponding period for last year reflecting an increase of 18.1%
§  Consolidated EBITDA stood at Rs 1,361 mn as compared to Rs 890 mn during the same period in the previous year reflecting an increase of 52.9%
§  Consolidated EBITDA Margin was at 11.5% for 9 Months FY16 as against 8.9% in 9 Months FY15
§  PAT after minority interest and share in associate stood at Rs 159 mn for 9 Months FY16 as compared to negative Rs (168) mn in the corresponding period for last year
 
As on 31st December, 2015, the consolidated net debt was Rs  1,740 mn representing a net debt to equity ratio of 0.19.
 
Other Highlights during the Quarter
§  One of our flagship hospitals, Mazumdar Shaw Medical Centre at Bangalore achieved the milestone of 500 Bone-Marrow Transplant procedures since its inception
§  Our hospital at Guwahati, Assam got NABH accreditation within 2 years of commencement of operations
 
Management Comment
Commenting on the performance, Dr. Ashutosh Raghuvanshi, Vice Chairman, Managing Director and Group CEO, Narayana Hrudayalaya Limited, said “Narayana Hrudayalaya’s Q3FY16 performance reflects the continued growth momentum and focus on financial and operational efficiencies inching up towards better profitability and sustained expansion. Our strategy of growth driven by calibrated capacity expansion & multiple layers of profitability drivers is aligned to the best interests of all the stakeholders. We thank you all for reposing faith upon us during the process of our company’s listing in the stock exchanges.”

About the Author

Sachin Murdeshwar
Sachin Murdeshwar is a Sr.Journalist and Columnist in several Mainline Newspapers and Portals.He is an ardent traveller and likes to explore destinations to the core.